Kenneth Janzon
Chief Tech/Sci/R&D Officer presso Nordvacc Läkemedel AB
Patrimonio netto: 396 723 $ in data 31/03/2024
Posizioni attive di Kenneth Janzon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Nordvacc Läkemedel AB
 Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The private company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Chief Tech/Sci/R&D Officer | - | - |
Storia della carriera di Kenneth Janzon
Precedenti posizioni note di Kenneth Janzon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INTERVACC AB | Director/Board Member | 01/01/2001 | 14/06/2018 |
| Founder | 01/01/2001 | 14/06/2018 | |
| Independent Dir/Board Member | 01/01/2001 | - |
Statistiche
Distribuzione geografica
| Svezia | 3 |
Posizioni
| Director/Board Member | 1 |
| Founder | 1 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 2 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INTERVACC AB | Health Technology |
| Aziende private | 1 |
|---|---|
Nordvacc Läkemedel AB
Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The private company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Distribution Services |
- Borsa valori
- Insiders
- Kenneth Janzon
- Esperienza
